advertisement
Jiang H 12
Showing records 1 to 12 | Display all abstracts from Jiang H99036 miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Xu L
Journal of Ophthalmology 2022; 2022: 3584192
98469 The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Jiang H
Experimental Eye Research 2022; 217: 108910
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Fang F
Molecular Therapy 2022; 30: 1421-1431
99036 miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Zhang Y
Journal of Ophthalmology 2022; 2022: 3584192
98469 The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Luo J
Experimental Eye Research 2022; 217: 108910
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Zhuang P; Feng X
Molecular Therapy 2022; 30: 1421-1431
99036 miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Long H
Journal of Ophthalmology 2022; 2022: 3584192
98469 The roles of mouse double minute 2 (MDM2) oncoprotein in ocular diseases: A review
Lei H
Experimental Eye Research 2022; 217: 108910
99036 miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Zhou B
Journal of Ophthalmology 2022; 2022: 3584192
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Liu P; Liu D
Molecular Therapy 2022; 30: 1421-1431
99036 miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-/SMAD2 Pathway
Jiang H
Journal of Ophthalmology 2022; 2022: 3584192
98727 NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Huang H; Li L; Chen W; Liu L; Sun Y; Jiang H; Ye J; Hu Y
Molecular Therapy 2022; 30: 1421-1431
